Electrophysiology Devices Market By Application 2022 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Electrophysiology Devices Market
Electrophysiology Devices Market: By Application (Cardiac Resynchronization Therapy, Holter Monitoring Devices, Electroretinograph, Electrocardiograph, Diagnostic Electrophysiology Catheters, Imaging and 3D Mapping Systems) & By Region-Forecast (2016-2022)
Report Code : HCR 0399
Published: 07 October, 2016   No. of pages: 131

  • Report Description
  • Table of Contents
  • Customization Options
Electrophysiology can be defined as the branch of medical science which involves the study of the electrical properties of biological cells and tissues and involves measurement of voltage change or electric current on a wide variety of scales from single ion channel proteins to whole organs like the heart. Globally, technological advancement in healthcare services and an increasing population with cardiac diseases as a result of life style are expected to be the key growth drivers during the period of study.

Electrophysiology Devices Market

Geographically, North America dominated the electrophysiology devices market driven by best in class healthcare infrastructure with advanced equipments, higher prevalence of cardiac arrhythmia in this region, majorly as a result of people leading unhealthy lifestyle habits, and higher spending on healthcare by citizens in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for the electrophysiology devices market. Asia Pacific is projected to have the fastest growth, owing to a rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.

This report identifies the electrophysiology devices market size for the years 2014-2016, and forecast of the same till year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the electrophysiology devices market.

This report segments the electrophysiology devices market on the basis of application and regional market as follows:
  • Electrophysiology devices market research report is classified on the basis of application. Some of the major applications covered in this report are as follows: Cardiac Resynchronization Therapy, Holter Monitoring Devices, Electroretinograph, Electrocardiograph, Diagnostic Electrophysiology Catheters, Imaging and 3D Mapping Systems, Electroencephalograph, Electromyograph, X-Ray, Electrocorticograph, Electrooculograph, Pacemakers, Implantable Cardioverter Defibrillators
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the electrophysiology devices market. Some of the major companies’ profiles in detail are as follows:

  • Biosense Webster, Inc. (A Johnson & Johnson Company)
  • St. Jude Medical Inc. 
  • Biotronik SE & Co. KG
  • Topera, Inc. (Recently Acquired By Abbott Laboratories)
  • Biotronik Se & Co.Kg
1. Electrophysiology devices Market – Overview
2. Executive Summary 
3. Electrophysiology devices Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Electrophysiology devices Market– Forces
   4.1. Drivers
      4.1.1. Technological Advancements 
      4.1.2. Growing Prevalence of Atrial Fibrillation
   4.2. Restraints
      4.2.1. Lack of Skilled and Experienced Electrophysiologists in Developing Nations
   4.3. Opportunities
      4.3.1. Emerging nations
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Electrophysiology devices Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Electrophysiology devices Market, By Application
   6.1. Electrophysiology Treatment Devices
      6.1.1. Cardiac Resynchronization Therapy
      6.1.2. Catheters
      6.1.3. Pacemakers
   6.2. Electrophysiology Monitoring Devices
      6.2.1. Holter Monitoring Devices
      6.2.2. Electroretinograph
      6.2.3. Electrocardiograph
      6.2.4. Diagnostic Electrophysiology Catheters
      6.2.5. Imaging and 3D Mapping Systems
      6.2.6. Electroencephalograph
      6.2.7. Electromyograph
      6.2.8. X-Ray
      6.2.9. Electrocorticograph
      6.2.10. Electrooculograph
      6.2.11. Implantable Cardioverter Defibrillators
7. Electrophysiology devices Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America 
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Electrophysiology devices Market – Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   9.1. Siemens Healthcare
   9.2. Boston Scientific
   9.3. Abbott Laboratories
   9.4. GE Healthcare
   9.5. Biosense Webster, Inc. (A Johnson & Johnson Company)
   9.6. St. Jude Medical Inc. 
   9.7. Biotronik SE & Co. KG
   9.8. Topera, Inc. (Recently Acquired By Abbott Laboratories)
   9.9.  Biotronik Se & Co.Kg
   9.10. Microport Scientific Corporation
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports